AdAlta Ltd. (AU:1AD) has released an update.
AdAlta Limited, a Melbourne-based clinical stage drug development company, has announced a change in its registered office and business address to La Trobe University’s Institute for Molecular Science. The company is known for its proprietary i-body technology platform, which is advancing unique therapeutics for diseases like lung fibrosis and cancer, and is expanding its pipeline through strategic partnerships and subsidiary formations.
For further insights into AU:1AD stock, check out TipRanks’ Stock Analysis page.
